effect antiplatelet agent combin platelet aggreg liver metastas human pancreat adenocarcinoma nude mous ampl evid hematogen metastasi abil tumor cell aggreg host platelet arachidon acid metabol platelet vessel wall metastat process sever preliminari trial platelet inhibitori agent ketoconazol inhibitor lipoxygenas thromboxan synthetas calcium antagonist forskolin stimul platelet adenyl cyclas indomethacin inhibitor cyclooxygenas combin effect platelet aggreg hepat metastas human pancreat tumor cell nude mice tumor cell anim control single-drug combin treatment group agent hr hr tumor cell inject day statist signific differ control single-treat group reduct liver tumor nodul liver surfac area tumor rang agent similar reduct liver tumor nodul rang inhibitori effect liver surfac area tumor single-treat group combin studi platelet aggreg human platelet-rich plasma 